Abstract

Fears related to COVID-19 (“coronavirus fears”) have emerged as a new psychological effect of the current COVID-19 pandemic and have been associated with psychological distress and impairment. Other adverse effects include an increase in anxiety and depression symptoms and the respective disorders. The purpose of the current study was to examine the incremental validity of coronavirus fears and transdiagnostic factors in the prediction of the severity of anxiety and depressive disorder symptoms. A sample of 144 adolescents [aged 12–18 years, 55 boys (38.2%) and 89 girls (61.8%)] most of whom showed elevated levels of anxiety and depressive disorder symptoms completed several self-report measures online assessing coronavirus fears, transdiagnostic vulnerability and protective factors, and emotion regulation strategies. Results based on a series of hierarchical multiple regression analyses revealed that coronavirus fears, negative affect, intolerance of uncertainty, acceptance/tolerance, rumination and suppression explained unique variance in the severity of anxiety and depressive disorder symptoms. Path analysis demonstrated that acceptance/tolerance, rumination and suppression mediated the association between higher level transdiagnostic factors and the severity of major depressive disorder symptoms. Findings provide support for the hierarchical transdiagnostic model of emotional disorders and suggest that clinicians should be aware of coronavirus fears. Also, the results warrant the need to consider transdiagnostic vulnerability and protective processes in the new protocols for the treatment of emotional disorders.

Highlights

  • Anxiety and depressive symptoms and disorders are very common mental health problems in adolescents

  • Zero-order correlations demonstrated that coronavirus fears were significantly related to anxiety disorder symptoms but not to depressive disorder symptoms

  • A main goal of the present study was to investigate the incremental validity of coronavirus fears in the prediction of anxiety and depressive disorder symptoms experienced during the COVID-19 pandemic crisis in a sample of adolescents, most of whom showed high levels of symptomatology

Read more

Summary

Introduction

Anxiety and depressive symptoms and disorders are very common mental health problems in adolescents. A meta-analysis of 41 studies conducted in 27 countries estimated a worldwide pooled prevalence in children and adolescents of any anxiety disorder of 6.5% and of any depressive disorder of 2.6% (Polanczyk et al, 2015). In a recent literature review, Sandín et al (2018) found that prevalence estimates of anxiety in children and adolescents vary significantly across studies, ranging from 8.3 to 32.4% for any anxiety disorder. Subclinical symptoms of anxiety and depression are very prevalent, having been estimated to be present in 32 and 29.2% of adolescents, respectively; likewise, these symptoms have been related to functional impairment and suicidality (Balázs et al, 2013)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call